WO2005110454A8 - Protective binding members of pyy for the treatment of metabolic disorders - Google Patents

Protective binding members of pyy for the treatment of metabolic disorders

Info

Publication number
WO2005110454A8
WO2005110454A8 PCT/DK2005/000329 DK2005000329W WO2005110454A8 WO 2005110454 A8 WO2005110454 A8 WO 2005110454A8 DK 2005000329 W DK2005000329 W DK 2005000329W WO 2005110454 A8 WO2005110454 A8 WO 2005110454A8
Authority
WO
WIPO (PCT)
Prior art keywords
pyy
treatment
metabolic disorders
binding members
protective binding
Prior art date
Application number
PCT/DK2005/000329
Other languages
French (fr)
Other versions
WO2005110454A2 (en
Inventor
Henrik Nilsson
Christian Hansen
Original Assignee
Aditech Pharma Ab
Henrik Nilsson
Christian Hansen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2005/000111 external-priority patent/WO2005079888A2/en
Application filed by Aditech Pharma Ab, Henrik Nilsson, Christian Hansen filed Critical Aditech Pharma Ab
Publication of WO2005110454A2 publication Critical patent/WO2005110454A2/en
Publication of WO2005110454A8 publication Critical patent/WO2005110454A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57545—Neuropeptide Y
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PCT/DK2005/000329 2004-05-18 2005-05-18 Protective binding members of pyy for the treatment of metabolic disorders WO2005110454A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200400789 2004-05-18
DKPA200400789 2004-05-18
PCT/DK2005/000111 WO2005079888A2 (en) 2004-02-19 2005-02-18 Delivery device for delivering pyy
DKPCT/DK2005/000111 2005-02-18

Publications (2)

Publication Number Publication Date
WO2005110454A2 WO2005110454A2 (en) 2005-11-24
WO2005110454A8 true WO2005110454A8 (en) 2005-12-22

Family

ID=35124383

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2005/000329 WO2005110454A2 (en) 2004-05-18 2005-05-18 Protective binding members of pyy for the treatment of metabolic disorders

Country Status (1)

Country Link
WO (1) WO2005110454A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236933B2 (en) * 2005-04-13 2012-08-07 Garvan Institute Of Medical Research Modified animal lacking functional PYY gene, monoclonal antibodies that bind PYY isoforms and uses therefor

Also Published As

Publication number Publication date
WO2005110454A2 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
AU2006274834A8 (en) Methods for preventing and treating metabolic disorders and new pyrazole-O-glycoside derivatives
ZA200607433B (en) Methods and compositions for the treatment of gastroin-testinal disorders
EP1731113B8 (en) Medical treatment kit
TWI369987B (en) New pharmaceutical compositions for the treatment of hyper-proliferative disorders
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
IL169332A0 (en) Compounds for the treatment of metabolic disorders
IL190920A0 (en) Compounds for the treatment of metabolic disorders
EP1727530A4 (en) Topical formulations for the treatment of skin conditions
AU2003286728A1 (en) Compounds for the treatment of metabolic disorders
AU2005254779A8 (en) Well treatment
ZA200902453B (en) PAI-1 binding modulators for the treatment of ocular disorders
EP1755637B8 (en) Methods for preventing or treating bone disorders
WO2006002203A8 (en) Methods and compositions for the treatment of polycystic diseases
WO2005110454A8 (en) Protective binding members of pyy for the treatment of metabolic disorders
EP2059238A4 (en) Therapeutic compounds for diseases and disorders
GB2433935B (en) Compounds for treating diabetes and related disorders
GB0427882D0 (en) Therapeutic uses for honey
AU2004904834A0 (en) Therapeutic Method - II
AU2004903380A0 (en) Treatments for CNS disorders
AU2004907252A0 (en) Therapeutic compounds
AU2004907275A0 (en) Therapeutic compounds
AU2004901689A0 (en) Therapeutic formulations
AU2004902388A0 (en) Methods for preventing or treating bone disorders
AU2004906949A0 (en) Therapeutic Agents
AU2004902166A0 (en) Treatment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

D17 Declaration under article 17(2)a
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase